Reactivation of a BCG Vaccination Scar Following the First Dose of the Moderna COVID-19 Vaccine

Joy Tao; David Rosenfeld; Jeffrey Hsu; Ashish Bhatia

doi:10.12788/cutis.0470

Reactivation of a BCG Vaccination Scar Following the First Dose of the Moderna COVID-19 Vaccine

Joy Tao, David Rosenfeld, Jeffrey Hsu, Ashish Bhatia

Dermatology

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

The devastating effects of the COVID-19 pandemic have prompted rapid development and distribution of multiple vaccines. A 2-dose messenger RNA (mRNA) vaccine developed by Moderna (Moderna COVID-19 Vaccine) was approved in December 2020 for the prevention of COVID-19. We describe a case of BCG vaccination scar reactivation in a 48-year-old man after he received the first dose of the Moderna COVID-19 Vaccine.

Original language	English (US)
Pages (from-to)	148-149
Number of pages	2
Journal	Cutis
Volume	109
Issue number	3
DOIs	https://doi.org/10.12788/cutis.0470
State	Published - Mar 2022

ASJC Scopus subject areas

Dermatology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.12788/cutis.0470

Cite this

@article{ac8fd5e2e839465db60a2d6789f1b998,

title = "Reactivation of a BCG Vaccination Scar Following the First Dose of the Moderna COVID-19 Vaccine",

abstract = "The devastating effects of the COVID-19 pandemic have prompted rapid development and distribution of multiple vaccines. A 2-dose messenger RNA (mRNA) vaccine developed by Moderna (Moderna COVID-19 Vaccine) was approved in December 2020 for the prevention of COVID-19. We describe a case of BCG vaccination scar reactivation in a 48-year-old man after he received the first dose of the Moderna COVID-19 Vaccine.",

author = "Joy Tao and David Rosenfeld and Jeffrey Hsu and Ashish Bhatia",

year = "2022",

month = mar,

doi = "10.12788/cutis.0470",

language = "English (US)",

volume = "109",

pages = "148--149",

journal = "Cutis",

issn = "0011-4162",

publisher = "Frontline Medical Communications Inc.",

number = "3",

}

TY - JOUR

T1 - Reactivation of a BCG Vaccination Scar Following the First Dose of the Moderna COVID-19 Vaccine

AU - Tao, Joy

AU - Rosenfeld, David

AU - Hsu, Jeffrey

AU - Bhatia, Ashish

PY - 2022/3

Y1 - 2022/3

N2 - The devastating effects of the COVID-19 pandemic have prompted rapid development and distribution of multiple vaccines. A 2-dose messenger RNA (mRNA) vaccine developed by Moderna (Moderna COVID-19 Vaccine) was approved in December 2020 for the prevention of COVID-19. We describe a case of BCG vaccination scar reactivation in a 48-year-old man after he received the first dose of the Moderna COVID-19 Vaccine.

AB - The devastating effects of the COVID-19 pandemic have prompted rapid development and distribution of multiple vaccines. A 2-dose messenger RNA (mRNA) vaccine developed by Moderna (Moderna COVID-19 Vaccine) was approved in December 2020 for the prevention of COVID-19. We describe a case of BCG vaccination scar reactivation in a 48-year-old man after he received the first dose of the Moderna COVID-19 Vaccine.

UR - http://www.scopus.com/inward/record.url?scp=85131702310&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85131702310&partnerID=8YFLogxK

U2 - 10.12788/cutis.0470

DO - 10.12788/cutis.0470

M3 - Article

C2 - 35659140

AN - SCOPUS:85131702310

SN - 0011-4162

VL - 109

SP - 148

EP - 149

JO - Cutis

JF - Cutis

IS - 3

ER -

Reactivation of a BCG Vaccination Scar Following the First Dose of the Moderna COVID-19 Vaccine

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this